1Life Healthcare (NASDAQ:ONEM – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage presently has a $8.50 price target on the stock. Zacks Investment Research‘s target price indicates a potential upside of 14.56% from the stock’s previous close.
According to Zacks, “1Life Healthcare Inc. provides software. The Company offers healthcare application for billing, insurance, planning and other related services. 1Life Healthcare Inc. is based in CA, United States. “
A number of other equities analysts also recently commented on ONEM. Citigroup lowered their price objective on 1Life Healthcare from $25.00 to $17.00 in a research report on Thursday, March 17th. Deutsche Bank Aktiengesellschaft decreased their target price on 1Life Healthcare from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 25th. SVB Leerink decreased their target price on 1Life Healthcare from $24.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, February 24th. Truist Financial decreased their target price on 1Life Healthcare from $24.00 to $12.00 in a research note on Thursday, February 24th. Finally, Morgan Stanley decreased their target price on 1Life Healthcare from $24.00 to $14.00 and set an “overweight” rating for the company in a research note on Thursday, February 24th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, 1Life Healthcare presently has a consensus rating of “Buy” and an average price target of $22.77.
1Life Healthcare (NASDAQ:ONEM – Get Rating) last released its earnings results on Wednesday, February 23rd. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.01). 1Life Healthcare had a negative net margin of 40.85% and a negative return on equity of 22.78%. The firm had revenue of $230.20 million during the quarter, compared to analyst estimates of $218.76 million. During the same period in the prior year, the firm earned ($0.06) earnings per share. The business’s revenue was up 89.0% compared to the same quarter last year. On average, analysts anticipate that 1Life Healthcare will post -1.89 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently modified their holdings of ONEM. Morgan Stanley raised its stake in shares of 1Life Healthcare by 27.5% during the second quarter. Morgan Stanley now owns 1,158,115 shares of the company’s stock worth $38,287,000 after purchasing an additional 250,082 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of 1Life Healthcare by 259.6% during the third quarter. SG Americas Securities LLC now owns 48,234 shares of the company’s stock worth $977,000 after purchasing an additional 34,822 shares during the last quarter. Los Angeles Capital Management LLC raised its stake in shares of 1Life Healthcare by 58.3% during the third quarter. Los Angeles Capital Management LLC now owns 45,262 shares of the company’s stock worth $917,000 after purchasing an additional 16,664 shares during the last quarter. Swiss National Bank raised its stake in shares of 1Life Healthcare by 0.7% during the third quarter. Swiss National Bank now owns 182,200 shares of the company’s stock worth $3,690,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of 1Life Healthcare by 2.8% during the third quarter. Principal Financial Group Inc. now owns 52,110 shares of the company’s stock worth $1,055,000 after purchasing an additional 1,405 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.
1Life Healthcare Company Profile (Get Rating)
1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.
- Get a free copy of the StockNews.com research report on 1Life Healthcare (ONEM)
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- Landstar Systems Stock Can Bottom Down Here
- 3M Stock is Worth a Look Because of the Company it Keeps
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.